Prosthetic innovation: ‘It’s like you have a hand again’ – The Jakarta Post – Jakarta Post

Today's artificial limbs can look very natural, and now an innovative process makes prosthetic hands move more naturally as well.

In an innovative experiment, scientists have shown that the nerves in patients' arms can be trained to control the movements of prosthetic fingers and thumbs.

"This is the biggest advance in motor control for people with amputations in many years," said Paul Cederna, a professor of plastic surgery and biomedical engineering at the University of Michigan.

A challenge to powering prosthetics has been the minute signals put out by an amputee's nerves. Cederna's team boosted the signal by wrapping tiny bits of muscle around nerve endings, according to their study published in Science Translational Medicine.

As the nerves grow into the muscle, the person's thoughts can create a muscle twitch that produces a signal big enough to be picked up by tiny wires connected to a nearby computer, which tells the prosthetic hand to move.

"Our ultimate goal is to have prosthetic limbs that the person views as a part of their body," Cederna said.

Read also: 'Ugly' prosthetics get French design treatment

In an example of how well the system works, a woman who was nervously tapping her own fingers prompted the prosthetic to tap right along with it, Cederna said. "It was just doing what the other hand was doing, like it was a part of her," he noted.

"This worked the very first time we tried it. There's no learning for the participants. All of the learning happens in our algorithms. That's different from other approaches."

The procedure also worked for another amputee in the study who had lost not only his hand, but also part of his arm.

"It's the coolest part of what they've shown," said Lee Fisher, an assistant professor in the University of Pittsburgh's department of physical medicine and rehabilitation and bioengineering.

Participants were able to pick up blocks with a pincer grasp, move their thumb in a continuous motion, lift spherical objects, and even play in a version of Rock, Paper, Scissors, according to the study.

The approach is an "exciting innovation", but no one can predict when it will be marketable, said David Putrino, co-director of the abilities research center at Mount Sinai Hospital in New York. "Currently it takes 17 years to get something (from the lab) out into clinical practice," he said.

Your premium period will expire in 0 day(s)

Subscribe to get unlimited access Get 50% off now

View post:
Prosthetic innovation: 'It's like you have a hand again' - The Jakarta Post - Jakarta Post

State Police: Cortland man threatened trooper with compound bow – Cortland Voice

WILLET --- A city man was arrested Friday for threatening a state trooper with a drawn compound bow after he and his girlfriend were discovered living in another persons Willet residence, according to police.

Michael Johnson, 38, and Elaine Smith, 38, were arrested after a trooper discovered them in the pre-dawn hours at a Mooney Hill home and Johnson threatened the officer with the bow, according to state police.

Troopers went to check on the residence at about 4 a.m. as state police were continuing to investigate the homeowners Tuesday report that someone had been living in his house, without his permission, police stated.

The homeowner was away from his house for several days and returned home Tuesday to find other peoples personal belongings in his residence, said Trooper Aga Dembinska, the public information officer for the locally stationed state police. State police were called at 5:40 p.m. to the residence on Tuesday regarding the trespassers, according to state records.

Investigators were able to identify potential suspects from the left-behind belongings and troopers returned Friday to check on the home, Dembinska said.

It was three hours before sunrise when a trooper looked into a window of the residence and saw a man pointing a drawn compound bow at him, according to state police. Troopers called Cortland County Sheriffs officers and a Cortland City Police officer to support them as they arrested the man, later identified as Johnson, police said.

Smith was also found at the Mooney Hill Road residence and arrested, according to state police records.

If struck with a compound bow at close range, the trooper could have suffered serious or deadly injuries, said Dr. Ian Dickey. Dickey is an emergency room doctor and orthopaedic surgeon who previously practiced at Guthrie Cortland Medical Center; he is also an adjunct professor of orthopaedic oncology and adult reconstruction at the University of Maine, where he is chair of the Bioengineering External Advisory Board, and is an assistant professor of orthopaedics at the University of Colorado.

Now this could be fatal if a torso wound, said Dickey, who now practices in Colorado. The arrows are able to inflict damage.

Dickey noted the stress of current events including COVID-19 and its financial effects as well as access to recreational and legitimate drugs could contribute to an increase of violent attacks during these uncertain times.

Johnson was charged with first-degree criminal trespass, third-degree criminal possession of a weapon and menacing a police officer, felonies, as well as the misdemeanor of second-degree menacing with a weapon. He was arraigned in Cortland County Court and remanded to the Cortland County Correctional Facility without bail.

Smith was charged with the misdemeanor second-degree criminal trespass and released on a ticket to appear on May 13 in Willet Town Court.

Read the rest here:
State Police: Cortland man threatened trooper with compound bow - Cortland Voice

Algae Oil Omega-3 Market by Types, Applications, Countries, Companies and Forecasts to 2025 covered in a Latest Research – Instant Tech News

The Algae Oil Omega-3 Market report market intelligence study intended to offer complete understanding of global market scenario. It attempts to analyze the major components of the Market which have greater influence on it. This includes various elements of significant nature including market overview, segmentation, competition landscape, Market chain analysis, key players review, and more. Also, the report examines worldwide Market on the basis of various analysis techniques including SWOT and Porters Five Forces. This might help readers to understand the strengths, opportunities, challenges and perceived threats of the market.

Algae Oil Omega-3 Market report further shares market intelligence in relevance with few more valuable aspects of the market such as regulation scenario, supply chain analysis, patents and standards, regional overview and more. While entailing variety of information related to each of the segments, the study strives evaluate each segment on various parameters in order to offer crystal clear view of it to readers.

Market Segmentation:The Algae Oil Omega-3 Market aims to categorize entire worldwide market into various segments for better understanding. This has been done based on numerous parameters including product type, service type, application, end use, technology, geographical region, etc. This provides detailed description of each segments which may help readers to understand the market into smaller parts of it. The study provides insights in relevance with several components of each segment including market share, revenue, past performance, growth drivers, future outlook and more.

Regional Update:The Algae Oil Omega-3 Market study enlists noteworthy details and analytically derived data figures related to regional markets. Here, the research delivers information in relevance with vital elements of each regional market including market share, sales, revenue, growth rate, major contributing countries, challenges, untapped opportunities and more. Few of the key regions covered in this report are North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa as well. This might help readers including stakeholders, investors, key vendors, suppliers, buyers, and others too in reaching smarter decisions in lesser time.

Key Players Analysis:Royal DSMLonza Group LtdCellana, Inc.Rishon International GroupHubei Fuxing BiotechnologyRunke Biological Engineering CompanyCargill Alking Bioengineering (Wuhan)

Owing to growing pace of growth, increasing demand, changing regional market scenarios and more factors of such nature, many companies have entered this Market in recent past. However, very few of it can be identified as key players of the Market. To name a few,

The Algae Oil Omega-3 Market report provides assessment of these key players where it attempts to analyze these companies on the basis of different parameters such as company profile, revenue, business overview, historic data figures, product or service portfolio, profits and more. This may share brief idea about competitive dashboard of the Market with readers.

In addition, it also enlists remarkable information in relevance with market dynamics including market growth drivers, challenges faced by key players, opportunities, new entrants tips, trends, etc.

There are 13 Chapters to thoroughly display the Algae Oil Omega-3 market. This report included the analysis of market overview, market characteristics, industry chain, competition landscape, historical and future data by types, applications and regions.

Chapter 1: Algae Oil Omega-3 Market Overview, Product Overview, Market Segmentation, Market Overview of Regions, Market Dynamics, Limitations, Opportunities and Industry News and Policies.Chapter 2: Algae Oil Omega-3 Industry Chain Analysis, Upstream Raw Material Suppliers, Major Players, Production Process Analysis, Cost Analysis, Market Channels and Major Downstream Buyers.Chapter 3: Value Analysis, Production, Growth Rate and Price Analysis by Type of Algae Oil Omega-3.Chapter 4: Downstream Characteristics, Consumption and Market Share by Application of Algae Oil Omega-3.Chapter 5: Production Volume, Price, Gross Margin, and Revenue ($) of Algae Oil Omega-3 by Regions (2020-2025).Chapter 6: Algae Oil Omega-3 Production, Consumption, Export and Import by Regions (2020-2025).Chapter 7: Algae Oil Omega-3 Market Status and SWOT Analysis by Regions.Chapter 8: Competitive Landscape, Product Introduction, Company Profiles, Market Distribution Status by Players of Algae Oil Omega-3.Chapter 9: Algae Oil Omega-3 Market Analysis and Forecast by Type and Application (2020-2025).Chapter 10: Market Analysis and Forecast by Regions (2020-2025).Chapter 11: Industry Characteristics, Key Factors, New Entrants SWOT Analysis, Investment Feasibility Analysis.Chapter 12: Market Conclusion of the Whole Report.Chapter 13: Appendix Such as Methodology and Data Resources of This Research.

Qurate Business Intelligence delivers unique Market research solutions to its customers and help them to get equipped with refined information and Market insights derived from reports. We are committed to providing best business services and easy processes to get the same. Qurate Business Intelligence considers themselves as strategic partners of their customers and always shows the keen level of interest to deliver quality.

Continue reading here:
Algae Oil Omega-3 Market by Types, Applications, Countries, Companies and Forecasts to 2025 covered in a Latest Research - Instant Tech News

LED Lighting for Horticulture Application Market: A Deep Dive Analysis of Various Regions and Strategies During Forecast Period 2019 2025. – News…

The LED Lighting for Horticulture Application market research encompasses an exhaustive analysis of the market outlook, framework, and socio-economic impacts. The report covers the accurate investigation of the market size, share, product footprint, revenue, and progress rate. Driven by primary and secondary researches, the LED Lighting for Horticulture Application market study offers reliable and authentic projections regarding the technical jargon.

All the players running in the global LED Lighting for Horticulture Application market are elaborated thoroughly in the LED Lighting for Horticulture Application market report on the basis of proprietary technologies, distribution channels, industrial penetration, manufacturing processes, and revenue. In addition, the report examines R&D developments, legal policies, and strategies defining the competitiveness of the LED Lighting for Horticulture Application market players.

Request Sample Report @ https://www.researchmoz.com/enquiry.php?type=S&repid=2460411&source=atm

In global market, the following companies are covered: CreeFluence BioengineeringHeliospectraHubbell LightingIllumitexKessil LightingLemnis OreonLumiGrowOsram SylvaniaSmart Grow Technologies

Market Segment by Product TypeLED LampLED Luminaire

Market Segment by ApplicationCommercial greenhouseIndoor and vertical farming

Key Regions split in this report: breakdown data for each region.United StatesChinaEuropean UnionRest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:To analyze and research the LED Lighting for Horticulture Application status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.To present the key LED Lighting for Horticulture Application manufacturers, presenting the sales, revenue, market share, and recent development for key players.To split the breakdown data by regions, type, companies and applications To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.To identify significant trends, drivers, influence factors in global and regionsTo analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of LED Lighting for Horticulture Application are as follows:History Year: 2014-2018Base Year: 2018Estimated Year: 2019Forecast Year 2019 to 2025

Make An EnquiryAbout This Report @ https://www.researchmoz.com/enquiry.php?type=E&repid=2460411&source=atm

Objectives of the LED Lighting for Horticulture Application Market Study:

The LED Lighting for Horticulture Application market research focuses on the market structure and various factors (positive and negative) affecting the growth of the market. The study encloses a precise evaluation of the LED Lighting for Horticulture Application market, including growth rate, current scenario, and volume inflation prospects, on the basis of DROT and Porters Five Forces analyses. In addition, the LED Lighting for Horticulture Application market study provides reliable and authentic projections regarding the technical jargon.

You can Buy This Report from Here @ https://www.researchmoz.com/checkout?rep_id=2460411&licType=S&source=atm

After reading the LED Lighting for Horticulture Application market report, readers can:

Continue reading here:
LED Lighting for Horticulture Application Market: A Deep Dive Analysis of Various Regions and Strategies During Forecast Period 2019 2025. - News...

The worlds of technology and food have fully collided in a good way – Wired.co.uk

GlobalP / narvikk / Getty Images / WIRED

The new discipline of bioengineering is going to dramatically impact how we produce and consume our food. The petroleum era ushered in many of the marquee companies and manufacturing processes of our generation names such as IBM, BP and Texaco. But we are increasingly aware of the impact these processes have had on the environment. We know that we need to reinvent manufacturing to improve our planet and our health.

Bioengineering which uses a range of approaches from electrical and mechanical engineering, computer and material sciences and, of course, biology marks a shift in our ability to change nature itself. In 2020, we will see biology eat the manufacturing world. New companies will spring up to reinvent the processes by which our food is grown, made and distributed.

Biology is already being engineered to reinvent many of the food processes and products born out of the petroleum era. Take Apeel, which uses nanotechnology to apply natures own protective peel material to fruits and vegetables, allowing them to last up to three times longer without refrigeration. This isnt just about keeping your strawberries fresh; Apeel is revolutionising logistics, as in many cases a cold chain is no longer needed, greatly decreasing cost and increasing optionality and directly addressing worldwide food waste.

Other companies have engineered products such as non-browning apples, by editing the gene that causes the apple to brown. These kinds of products are better for consumers and help our global systems by extending global trade routes, opening up new markets and reducing food waste on a global scale.

And of course we are seeing a move into plant-based meat. Companies such as Impossible Foods and Beyond Meat are already gaining traction with consumers. They have created an alternative to meat without the downsides of the traditional meat industry, such as methane production, consumption of grain, and E coli contamination. In 2020, we will see this industry shift further into bioengineered meat made directly from animal cells and requiring neither the birth nor slaughter of more animals.

This approach to manufacturing will spill over into many other food products. Dairy alternatives are already being produced in ways that dont involve cows, from new plant products such as oat milk to milk products that can be grown in plants instead of secreted by cows. Fish, too, will also increasingly be grown from these techniques, helping to address problems such as overfishing, environmental concerns and toxic materials in our aquatic ecosystems.

These products, designed by humans using natures own processes, will be revolutionary in the impact they have on our global economies and the worlds health. And the way they are produced will spill over into other sectors. As bioengineering eats our food system, the biology of our food will in turn eat more of our manufacturing. Companies such as Mycoworks and Bolt are already using materials such as mushrooms to create leather, and well see much more of that things like tree lights and houses that are grown instead of built. We are now seeing the first wave of a coming era in biological innovation, and companies in the sector will become as big as those that came before a bio Del Monte or Cargill for the 21st century.

In 2020, the advances in bioengineering in academia and in industry mean that we will finally have the capability and technology to replace the worlds faulty systems.

Vijay Pande is a general partner at Andreessen Horowitz

The most exciting electric cars coming in 2020

These mental tricks can help you go vegan this January

SUVs are worse for the planet than anyone realised

Science says we should work shorter hours in winter

How to use psychology to get people to answer your emails

Get The Email from WIRED, your no-nonsense briefing on all the biggest stories in technology, business and science. In your inbox every weekday at 12pm sharp.

by entering your email address, you agree to our privacy policy

Thank You. You have successfully subscribed to our newsletter. You will hear from us shortly.

Sorry, you have entered an invalid email. Please refresh and try again.

Visit link:
The worlds of technology and food have fully collided in a good way - Wired.co.uk

Are we closer to being able to print a functioning artificial ovary? – Medical News Bulletin

Approximately one in six female cancer survivors suffer from early menopause due to the serious side-effects of chemotherapy. Clinically known as premature ovarian insufficiency, this condition manifests as an inability of the ovaries to release eggs and the female sex hormone estrogen. Early menopause has long-term effects beyond fertility issues such as osteoporosis, low thyroid function, and increased risk of heart disease.

Scientists at Northwestern University, U.S., have worked on a possible solution to this probleman artificial ovary. Dr. Monica Laronda and her team at Northwestern University Feinberg School of Medicine have been working on developing an artificial ovary. In 2017, they implanted a functional 3-D printed artificial ovary in a sterile mouse that was then able to become pregnant and had live pups. Building on this groundbreaking work, Dr. Laronda and her team have taken a major step forward towards translating this technique for human use in the future. They have identified and mapped proteins in the pig ovary that form the scaffold for the different compartments within the ovary, similar to compartments found in the human ovary. Identifying and mapping these structural proteins are the first step towards developing a bio-ink or suitable biological material that can be used to 3-D print a bioprosthetic ovary for human use. The results of their latest work were recently published in Scientific Reports.

A major challenge in the field of bioprinting is the development of suitable biomaterials that can mimic the structure and functions of tissues and organs. This is especially true in the case of complex organs such as the ovaries that are comprised of different compartments with distinct functions. The human ovary is divided into two distinct compartments: the cortex that contains the immature follicles, which are maintained in a quiescent state, and the medulla that contains and supports the growing follicles. The ovarian follicle responds to molecular signals such as hormones as well as physical stress, to mature and eventually ovulate, releasing the single egg contained in the follicle.

It is hypothesized that the extracellular matrix plays a major role in the follicles remaining dormant or being activated into maturation. For instance, in mouse ovaries, physical compression of the primordial follicles in the cortex is necessary to maintain them in a quiescent state. Thus the work carried out by Dr. Laronda in identifying and mapping the structural proteins that make up the extracellular matrix is a key step towards being able to construct a functional artificial ovary for human use. As Dr. Laronda remarked in a recent press release, Our goal is to use the ovarian structural proteins to engineer a biological scaffold capable of supporting a bank of potential eggs and hormone-producing cells. Once implanted, the artificial ovary would respond to natural cues for ovulation, enabling pregnancy.

The technique developed by these researchers to process, identify, and map structural proteins in the extracellular matrix can be extended to study other organs and hence improve bioengineering methods involved in tissue regeneration or bioprinting. Dr. Laronda says, We have developed a pipeline for identifying and mapping scaffold proteins at the organ level. It is the first time that this has been accomplished and we hope it will spur further research into the microenvironment of other organs.

While there is a long way to go before we can print a functioning ovary for human use, the work presented in this report is a huge step forward for girls who undergo fertility-damaging cancer treatments.

Written by Bhavana Achary, Ph.D

References:

Henning, N.F., LeDuc, R.D., Even, K.A.et al.Proteomic analyses of decellularized porcine ovaries identified new matrisome proteins and spatial differences across and within ovarian compartments.Sci Rep9,20001 (2019). https://doi.org/10.1038/s41598-019-56454-3

Press release retrieved from https://www.eurekalert.org/pub_releases/2020-01/arh-st010620.php

Impact of premature ovarian insufficiency- https://www.nichd.nih.gov/health/topics/poi/conditioninfo/conditions

Image bytherapracticefromPixabay

See the article here:
Are we closer to being able to print a functioning artificial ovary? - Medical News Bulletin

Genetically engineered moths have been released into the wild to wipe out pests – KTVZ

Genetically modified diamondback moths designed to wipe out wild pest populations were released in fields for the first time in New York state.

Diamondback moths are migratory pests found in the Americas, Europe, New Zealand and Southeast Asia, but especially in areas where crops can be grown yearround.

In these parts where its not too hot nor too cold are where diamondback moths cause the greatest problems, including billions of dollars in damages to cruciferous crops such as cabbage, broccoli, cauliflower and canola. Theyre one of the most damaging insects because of their high reproduction rate and resistance to most insecticides.

To address these problems in a sustainable, environmentally friendly way, researchers have successfully genetically engineered (GE) male diamondback moths to control the pest population of their wild counterparts, according to findings published Wednesday in the journal Frontiers in Bioengineering and Biotechnology.

Theres a lot of interest in using genetically engineered insects for controlling medically important diseases, said Anthony Shelton, lead author of the study and entomology professor at Cornell Universitys College of Agriculture and Life Sciences.

In agriculture, though, I think we can take the advantage of genetically engineered insects to control a major pest species.

The moths were engineered by Oxitec, a developer of insect biological control systems that is known for its modified mosquito releases to reduce mosquitoes that carry malaria or dengue fever.

When rearing the moths, developers incorporated what they call a self-limiting gene that makes female offspring die shortly after hatching.

Typically, tetracycline, an antibiotic used to suppress the gene, is included in the moths diet so that female moths can be produced as well.

However, when you want to release populations of males, you do not include tetracycline, Shelton said. So all the female larvae that are feeding on the artificial diet will die. And then youll just have thousands and thousands of males which you can release in the field.

In cabbage field studies in Geneva, New York (about 260 miles from New York City) the moths were marked with different fluorescent powders, released together, then captured in a trap. The GE moths behaved similarly to their wild counterparts in regard to factors that would determine their potential to suppress pests.

They traveled the same distance and survived roughly as much as their wild counterparts did, in a ratio of two modified insects to one wild type, which was remarkable because in previous programs the ratio was much higher, Shelton said.

The GE moths also competed equally to the wild moths for female mates. However, wild female moths that mate with GE moths will not produce viable offspring the self-limiting gene passed to offspring prevents them from surviving, leading the authors to conclude that with ongoing releases, pests can be suppressed in a targeted, sustainable way without using insecticides.

The GE moths would eventually have no one to mate with, which means they would decline as well and disappear from the environment within a few generations, the authors said. More releases would be needed to continue to suppress wild populations.

With a method that could largely reduce the amount of pests and insecticides needed to eradicate them, the potential impact for the growers and producers of those crops is huge, said Alton Sparks, an entomology professor in the University of Georgias College of Agriculture.

If this works and can be implemented, it would make my job a lot easier for this one specific group of crops, said Sparks. Ive been battling diamondback moths on crops in South Texas and here [in Georgia] for 32 years.

Shelton previously conducted greenhouse studies in which they had diamondback moths feeding on broccoli. They had similar findings regarding pest suppression and elimination, but they also had moths that were resistant to insecticides.

Though the field releases have been successful, the practice isnt that common, as its only been used on a few insects.

If the technology works, it has tremendous potential, but its a very small set of agriculture because diamondback moths only affect a very small group of crops, Sparks said.

There have been programs funded by the Bill & Melinda Gates Foundation and the US Food and Drug Administration that are geared toward modifying insects to fight diseases and illnesses including the ZIka virus, malaria and dengue fever.

In 2016, the FDA cleared a modified mosquito developed by Oxitec for a field trial in Florida, saying that it hadnt found any negative effect on human health or the environment.

Some of these programs have been successful: From 2013 to 2015, Oxitec released roughly 450,000 modified male mosquitoes, which reduced the overall population by about 90%.

However, modifying insects is controversial, as the long term effects are unknown.

Many experts agree that more studies are needed to determine the long term effects of genetically engineering insects and whether manipulating genes upsets natural ecological cycles.

As for concerns for human health, Shelton said that contrary to the effect of insecticides on human health and the environment, the upside for GE insects is that the process is species specific, as theyll only mate with each other.

So, its not going to affect pollinators, Shelton said. Its not going to affect biological control organisms and its not going to affect human health.

Additional, longer studies are needed to fully assess modified moths ability to suppress pests and reduce insecticide resistance.

We all live in the age of genetics, Shelton said. Whether it be looking at your family tree or genetically engineering plants, we just know so much more about the genes in insects that we can now utilize this knowledge to control the pest populations in a much more environmentally friendly way and a much more sustainable way.

Read the original post:
Genetically engineered moths have been released into the wild to wipe out pests - KTVZ

Engineered Protein Assemblies that Respond to Cues Open Path for Smart, Protein-Based Medicines | Newsroom – UC Merced University News

By Michelle Morgante, UC Merced

Proteins are miniscule machines inside the body, about 10,000 times smaller than the thickness of human hair. They control all the processes of life like how cells communicate to each other, how the immune system combats infection, how muscles contract, and how oxygen is picked up in the lungs and delivered to those very same muscles.

Proteins can do all of this because they change shape, assemble and interact with other biomolecules in response to specific cues. This general property makes proteins extremely attractive targets for a variety of applications in medicine, environment, food industry and energy. But it also has proven very difficult to harness. Now, bioengineering Professor Victor Muoz has made a key discovery that could allow scientists to engineer adaptive proteins and convert them into powerful technological applications, including smart medicines.

In a paper published Dec. 13 in Nature Communications, Muoz and a team of researchers describe how they were able to engineer proteins to form assemblies, dissociate and change shape in response to signals. The discovery could allow scientists to, for example, use proteins to deliver drugs in a way that is less toxic and more targeted than current practices.

Proteins in their natural state are easily passed through the kidney, meaning they are not in the blood long enough to act as an effective medicine.

But when a protein makes an assembly, Muoz said. It forms structures that are larger and sturdier and dont get secreted out of the kidney. They stay in the blood for a longer time.

Muoz, who is director of UC Merceds Center for Cellular and Bio-Molecular Machines (CCBM-CREST), said research for this project began a decade ago and has involved collaboration from several groups around the world. The work to figure out how to engineer proteins to act as nanomachines has been challenging and tortuous.

They do all these complicated things and are so small. That means their design principles and organization are incredibly sophisticated, he said. People have been able to design proteins that will form particular assemblies of many different shapes, but they have not been able to make them adaptive so they switch their shape and properties in response to stimuli.

"This opens the gate for developing drugs that are based on proteins in a way they could be delivered as inactive assemblies that remain in the blood as needed to then be activated on cue at a given time or in a specific location in the body."

director, Center for Cellular and Bio-Molecular Machines

The discovery may lead to important applications in biosensor research, medicine, diagnostics, vaccines, bioremediation anything you could imagine, Muoz said.

In medical applications, for example, proteins engineered this way could become a new technology for the smart delivery of specific drugs.

This would have enormous advantages over conventional drugs, which are much less specific, more toxic and can cause a range of harmful side-effects. It could also help store an inactive version of the protein in blood for a relatively long time, eliminating the short lifespan curse of current protein pharmaceuticals.

This opens the gate for developing drugs that are based on proteins in a way they could be delivered as inactive assemblies that remain in the blood as needed to then be activated on cue at a given time or in a specific location in the body, Muoz said.

The next step, Muoz said, will be to try the process in other systems and see whether it can be generalized. This was a proof of concept. Next, wed like to target systems that have more interesting applications to exploit the possibility of making this into a real technology thats useful.

See original here:
Engineered Protein Assemblies that Respond to Cues Open Path for Smart, Protein-Based Medicines | Newsroom - UC Merced University News

The omega-3 market is projected to grow at a CAGR of 13.1% from 2019 to 2025 – P&T Community

NEW YORK, Dec. 26, 2019 The omega-3 market is projected to grow at a CAGR of 13.1% from 2019 to 2025.The global omega-3 market size is estimated to be valued at USD 4.1 billion in 2019 and is projected to reach USD 8.5 billion by 2025, recording a CAGR of 13.1%. Consumer awareness regarding the health benefits of omega-3 and an increase in application profiling and existing applications finding new markets are some of the significant factors that have led to surge in demand for omega-3 supplements. These factors are projected to drive the growth of the global omega-3 market.

Read the full report: https://www.reportlinker.com/p03670113/?utm_source=PRN

The dietary supplement segment is projected to be the largest segment in the omega-3 market, by application, during the forecast period.Omega-3 increasingly finds application in dietary supplements, functional foods & beverages, pharmaceuticals, infant formula, and pet food and feed. Dietary supplements are estimated to account for the largest market due to the fast-paced and busy lifestyles; consumers prefer consuming dietary supplements to make sure that they get their optimal share of nutrients, and omega-3 supplements are used to improve the health and performance, wherein athletes are advised adequate intake of omega-3 fatty acids for fit and healthy body.

The docosahexaenoic acid (DHA) segment to witness the fastest and largest growth in the omega-3 market, by type, during the forecast period.By type, the market is segmented into docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and alpha-linolenic acid (ALA).Docosahexaenoic acid (DHA) is the most important omega-3 fatty acid and plays a key role in the development of brain and retina in infants.

The intake of docosahexaenoic acid (DHA) helps in the prevention of cardiovascular diseases and lowering triglyceride levels.

North America is estimated to account for the largest market share in 2019.The North American omega-3 market is estimated to account for the largest share in the global market in 2019.The demand for omega-3 based products has been increasing in the region-specific in the brain and heart health applications.

The omega-3 market in North America is primarily dominated by the US, as the adults prefer to consume fish oil sourced omega-3 capsules as dietary supplements. Also, the omega-3 deficiency among the citizens in the US and Canada has highly impacted the surge in demand for omega-3-based products.

Break-up of Primaries By Value Chain: Demand-side - 45% and Supply-side- 55% By Designation: C level - 33%, D level - 41%, and Others - 26% By Region: Europe - 29%, North America - 27%, Asia Pacific - 22%, South America - 13%, RoW - 9%

Leading players profiled in this report Cargill (US) BASF (Germany) DSM (Netherlands) Croda International (UK) Epax (Norway) Lonza (Switzerland) Orkla Health (Norway) Corbion (Netherlands) KD Pharma (Germany) GC Rieber (Norway) Guangdong Runke Bioengineering (China) Nordic Naturals (US) Golden Omega (Chile) Biosearch Life (Spain) Pharma Marine (Norway) Polaris (France) Sinomega Biotech Engineering (China) Huatai Biopharm (China) Kinomega Biopharm (China) Algisys (US)

Research CoverageThis report segments the omega-3 market into application, type, source, and region. In terms of insights, this research report focuses on various levels of analysescompetitive landscape, end-use analysis, and company profileswhich together comprise and discuss the basic views on the emerging & high-growth segments of the omega-3 market, the high-growth regions, countries, government initiatives, market disruption, drivers, restraints, opportunities, and challenges.

Reasons to buy this report To get a comprehensive overview of the omega-3 market To gain wide-ranging information about the top players in this industry, their product portfolios, and key strategies adopted by them To gain insights about the major countries/regions, in which the omega-3 industry is flourishing

Read the full report: https://www.reportlinker.com/p03670113/?utm_source=PRN

About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

View original content:http://www.prnewswire.com/news-releases/the-omega-3-market-is-projected-to-grow-at-a-cagr-of-13-1-from-2019-to-2025--300979389.html

SOURCE Reportlinker

Read more here:
The omega-3 market is projected to grow at a CAGR of 13.1% from 2019 to 2025 - P&T Community

Renowned scientists address ethics, ‘twin scientific revolutions’ of AI and CRISPR – The Stanford Daily

President Marc Tessier-Lavigne introduced two women, each renowned in their respective fields, as scientific trailblazers to a packed CEMEX auditorium of 600 people on Monday. Jennifer Doudna, a biochemist who invented CRISPR, and Fei-Fei Li, who currently heads the Human-Centered Artificial Intelligence (HAI) endeavor, discussed the twin revolutions of CRISPR and artificial intelligence with moderator Russ Altman, a bioengineering professor.

But beyond just talking about those innovations, Tessier-Lavigne noted the significant urgency present to consider the broader societal impacts of their work: to notice both the promise and peril that accompany innovation.

Innovation alone isnt sufficient, Tessier-Lavigne said. Creating a disruption does not guarantee positive effects for our society or for individuals. Disrupting just for disruptions sake is no honorable activity. Remarkable opportunities for good can also be misused.

Doudna and Lis work has been influential within the fields of gene editing and artificial intelligence, respectively. Doudna and her team developed the technology known as CRISPR-Cas9, which allows for the editing of DNA and genomes as well as for a myriad of control applications within the body and potential development of biotechnology products.

Li was the leading scientist of ImageNet, a database used in visual object recognition software that enables computers to recognize a wide variety of human, everyday objects through machine learning.

Both speakers acknowledged the ethical concerns looming over these innovations. This beginning of a revolution in deep learning is accompanied by the threat of ethical complications such as eugenics, patentability and heritable genome editing.

The recognition ability [of ImageNet] is in the background of Google searches when you use Facebook or when you communicate with your phone; its always present, Altman said, adding that recent developments in AI have caused the field to become a breeding ground of questions surrounding ethics.

When asked if it was obvious that the results were going to lead to such an explosive reaction both inside and out of the scientific community, Li said that she knew they were approaching a holy grail question.

We were granting the computers an ability that took humans 540 million years of evolution to achieve, she said. I would be lying, however, if I said I recognized the societal implications of the work at the time.

Doudna replied similarly, saying that for those of us working in the world of CRISPR, it was a very esoteric area of biology back then. It was surprising to see that our very esoteric area was merging with a very important part of biotechnology.

Could I have predicted the advancements, CRISPR babies? she asked, referring to former Stanford postdoctoral fellow He Jiankui who launched international controversy when he announced he created the worlds first gene-edited babies using CRISPR technology. Definitely not, but it was a very exciting progression.

A significant part of the discussion centered on ethics, with Altman asking the innovators about their engagement with ethics throughout their research. Doudna recalled 2012 as the year that a moral obligation really arose in her life. After reading a published article of CRISPR being applied to human primates, she recalled realizing the potential for genome editing in humans.

I was quite reluctant, but I did feel a real responsibility to engage in the discussion at that point, Dounda said.

Li also described her surprise when her own career in AI came under public scrutiny, with some critics calling genome editing a field summoning a demon.

While major parts of their professional journeys align, their paths diverge in terms of confronting the ethical problems of their work. To combat the potential misuses of CRISPR, Doudna felt like the scientific community really needed to [be] engaged as a whole. She convened meetings to broach the subject of the morality behind CRISPR applications and recalls thinking that that was the beginning of my education in ethics I felt like a student learning how to think about this and how to approach it.

Lis approach was different because CS was a much younger discipline, without an ethics sub-area, and I didnt know who to talk to. She decided to turn her focus to the drivers of AI, the human representation in the field, especially to diversify the field and open it up to more women and minorities.

Li went on to start the program AI4ALL, which began at Stanford and then grew to become nationally recognized 500 alumni of the program and 11 college campuses that host the students, all with the mission of engaging underrepresented students in underserved communities.

The academic pioneers were then asked about the exposure of young scientists to ethical information, with both agreeing that there needed to be more educating done in their fields.

Its a cultural thing in our field, Doudna said. We are in the vein of creating scholars in our specific subject rather than creating a group of holistically knowledgeable people.

Li added that students of mine dont even have the language to talk about these issues.

Altman went on to note that these are unlikely to be the last scientific revolutions. He wondered what advice the two women had for handling these explosive introductions of research.

We definitely havent seen the end of the AI story its just the beginning, Li answered. We need to invest in people. Diversity and inclusion is a way to ensure that we maximize human representation during these times.

As for representation in policy, Doudna said she would like to see more scientists in Congress.

I was really struck when I met with Bill Foster and he pointed out that he was the only Ph.D. in congress, Doudna said. I think we need to see more representation.

As for their hopes for their work moving forward, their visions were the same: an international framework to cooperate and communicate. Li noted that there are issues of warfare, bioterrorism and a myriad of other potential dangers. She noted that every discovery has a dual potential, which is why we need laws, ethical principles, an international framework given how powerful these technologies are.

Contact Hannah Shelby at hshelby at stanford.edu.

Originally posted here:
Renowned scientists address ethics, 'twin scientific revolutions' of AI and CRISPR - The Stanford Daily

Building the Body | News Center – UNLV NewsCenter

Laypeople may think of engineering as being more about numbers and materials than human beings. But thats not the case, especially with bioengineering. Its a field that synthesizes engineering techniques with the biological sciences. Electrical and computer engineering professor Pushkin Kachroo and his department have been committed to expanding bioengineerings reach since his arrival at UNLV more than 10 years ago. With the creation of the universitys School of Medicine, the opportunities for collaboration are growing.

Its a common-sense link that health, medicine and engineering, should be connected together, Kachroo said. Thats where health is going.

Thanks to the new Howe Fellowship in Bioengineering at UNLV, the work of two engineering graduate students is getting a boost in showcasing the ways engineering can materially benefit human health and well-being.

Lina Chato was always good at math growing up in her native Iraq, but she found her real passion when her school opened a new computer lab. Fellow students showed her some simple programs, let her borrow books, and before long she had written her first program about computer-aided learning for electrical circuit design. She was only 13 years old.

Chato received a bachelors degree in computer engineering and a masters degree in mechatronics engineering from the University of Technology, Baghdad. She joined the faculty and published three papers, but when the country became unstable due to the war, she fled with her family to the United States. She settled in Las Vegas, where two of her sisters already lived, and applied to UNLV's College of Engineering. Chato worked as a research assistant before beginning her doctorate program.

I came as a refugee, without any source of money, she said. This first opportunity was really appreciated and important to start my Ph.D. study.

Chato became interested in using machine learning to try to better analyze MRI images of brain tumors. Her work revolves around developing models to predict survival time for Glioma tumor patients. These types of tumors represent nearly three quarters of all malignant tumors.

We still dont know how these tumors behave, she said. The behavior of tumors is an important factor in predicting survival. This model can describe how a brain tumor develops. If we can know that, we can use this in the treatment stage.

When he graduated from the Las Vegas Academy of the Arts, Jadin Tredup wasnt sure what he wanted to do pursue music or study math. So he entered UNLVs then newly created entertainment engineering program.

It seemed like a pretty good blend of the two, Tredup said.

At UNLV his focus shifted away from music toward mechanical engineering, and then again toward electrical engineering. His journey took him from robotics to machine learning and artificial intelligence, to the problem of applying brain wave signals.

Now, having just finished his masters degree, hes working on a model to help patients he characterizes as having profound intellectual and multiple disabilities people with very severe and limited cognitive and motor functioning and an inability to communicate verbally.

The idea is, because our bodies carry so much more information beyond what we can produce in words, if we can sense all these physiological signals we can then translate them using AI and machine learning into a language and vocabulary for people, he said.

Tredups work leverages a theory about how the environment impacts how we communicate. For instance, EEGs can measure brain waves and translate them into emotional states; sensors can measure galvanic skin response (sweat, basically, an indicator of emotional state); and eye tracking can measure what patients are paying attention to. They can detect nearly instantaneous changes, allowing researchers to deduce, for example, that a barking dog might be causing anxiety. You can translate the data into a basic language, like Im feeling anxious because of the dog barking.

The next step is to develop a needs assessment for a few specific patients at a care facility, then further develop the algorithm.

No one model is easily applicable person-to-person, Tredup said. We have to create a generalizable model.

Tredup began his doctorate program at UNLV this fall. (He is the fourth in his family after his parents and brother to graduate from UNLV.) The Howe Foundation Fellowship will afford him more time to concentrate on research instead of juggling full-time research and a full-time job. Similarly, Chatos award will help her focus more energy on her research and spend less time as a teaching assistant.

Working with algorithms is cool, but it doesnt mean much unless it has applicability to the world around it, said Tredup. I can use everything Ive learned and help better peoples lives.

Read the rest here:
Building the Body | News Center - UNLV NewsCenter

Largest Study Finds Greater Reduction in Risk of CVD and Death From Bedtime Rather Than Morning Medication – Cath Lab Digest

October 30, 2019 People with high blood pressure who take all their anti-hypertensive medication in one go at bedtime have better controlled blood pressure and a significantly lower risk of death or illness caused by heart or blood vessel problems, compared to those who take their medication in the morning, according to new research.

The Hygia Chronotherapy Trial, which is published in the European Heart Journal [1] is the largest to investigate the effect of the time of day when people take their anti-hypertensive medication on the risk of cardiovascular problems. It randomised 19,084 patients to taking their pills on waking or at bedtime, and it has followed them for the longest length of time -- an average of more than six years -- during which time the patients' ambulatory blood pressure was checked over 48 hours at least once a year.

The researchers, who are part of the Hygia Project led by Professor Ramn C. Hermida, Director of the Bioengineering and Chronobiology Labs at the University of Vigo, Spain, found that patients who took their medication at bedtime had nearly half the risk (45% reduction) of dying from or suffering heart attacks, myocardial infarction, stroke, heart failure or requiring a procedure to unblock narrowed arteries (coronary revascularisation), compared to patients who took their medication on waking.

The researchers had adjusted their analyses to take account of factors that could affect the results, such as age, sex, type 2 diabetes, kidney disease, smoking and cholesterol levels.

When they looked at individual outcomes, they found that the risk of death from heart or blood vessel problems was reduced by 66%, the risk of myocardial infarction was reduced by 44%, coronary revascularisation by 40%, heart failure by 42%, and stroke by 49%.

Prof Hermida said: "Current guidelines on the treatment of hypertension do not mention or recommend any preferred treatment time. Morning ingestion has been the most common recommendation by physicians based on the misleading goal of reducing morning blood pressure levels. However, the Hygia Project has reported previously that average systolic blood pressure when a person is asleep is the most significant and independent indication of cardiovascular disease risk, regardless of blood pressure measurements taken while awake or when visiting a doctor. Furthermore, there are no studies showing that treating hypertension in the morning improves the reduction in the risk of cardiovascular disease.

"The results of this study show that patients who routinely take their anti-hypertensive medication at bedtime, as opposed to when they wake up, have better-controlled blood pressure and, most importantly, a significantly decreased risk of death or illness from heart and blood vessel problems." [2] [3]

The Hygia Project is composed of a network of 40 primary care centres within the Galician Social Security Health Service in northern Spain. A total of 292 doctors are involved in the project and have been trained in ambulatory blood pressure monitoring, which involves patients wearing a special cuff that records blood pressure at regular intervals throughout the day and night. The Hygia Chronotherapy Trial is unusual in monitoring blood pressure for 48 hours, rather than the more usual 24 hours.

Between 2008 and 2018, 10,614 men and 8,470 women of Caucasian Spanish origin, aged 18 or over, who had been diagnosed with hypertension by means of ambulatory blood pressure monitoring, were recruited to the trial; they had to adhere to a routine of daytime activity and night-time sleep, which means that it is not possible to say if the study findings apply to people working night shifts.

Doctors took the patients' blood pressure when they joined the study and at each subsequent clinic visit. Ambulatory blood pressure monitoring over a 48-hour period took place after each clinic visit and at least once a year. This gave doctors accurate information on average blood pressures over the 48 hours, including how much blood pressure decreased or 'dipped' while the patients were asleep.

During a median (average) of 6.3 years follow-up, 1752 patients died from heart or blood vessel problems, or experienced myocardial infarction, stroke, heart failure or coronary revascularisation. Data from ambulatory blood pressure monitoring showed that patients taking their medication at bedtime had significantly lower average blood pressure both at night and during the day, and their blood pressure dipped more at night, when compared with patients taking their medication on waking. A progressive decrease in night-time systolic blood pressure during the follow-up period was the most significant predictor of a reduced risk of cardiovascular disease.

Prof Hermida concluded: "The findings from the Hygia Chronotherapy Trial and those previously reported from the Hygia Project indicate that average blood pressure levels while asleep and night-time blood pressure dipping, but not day-time blood pressure or blood pressure measured in the clinic, are jointly the most significant blood pressure-derived markers of cardiovascular risk. Accordingly, round-the-clock ambulatory blood pressure monitoring should be the recommended way to diagnose true arterial hypertension and to assess the risk of cardiovascular disease. In addition, decreasing the average systolic blood pressure while asleep and increasing the sleep-time relative decline in blood pressure towards more normal dipper blood pressure patterns are both significantly protective, thus constituting a joint novel therapeutic target for reducing cardiovascular risk."

The Hygia Project is currently investigating what the best blood pressure levels should be while asleep in order to reduce cardiovascular risk most effectively in the THADEUS Trial (Treatment of Hypertension During Sleep). [4]

Limitations of the Hygia Chronotherapy Trial include that it requires validation in other ethnic groups; the question of whether the same results would be seen in shift workers also requires investigation; and patients were not assigned to specific hypertension medication classes or specific lists of medications within each class -- their treatment was chosen by their doctors according to current clinical practice.

References

[1] "Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial," by Ramn C. Hermida et al. European Heart Journal. doi:10.1093/eurheartj/ehz754

[2] Hygia Project, "Asleep blood pressure: significant prognostic marker of vascular risk and therapeutic target for intervention," by Ramn C. Hermida et al. European Heart Journal, 2018;39:4159-4171, doi:10.1093/eurheartj/ehy475

[3] Systolic blood pressure is the pressure in the arteries as the heart contracts to eject blood out into them. Diastolic blood pressure is the pressure in the arteries between heart beats when the cardiac muscles relax.

[4] Treatment of Hypertension During Sleep (THADEUS), https://clinicaltrials.gov/ct2/show/NCT03457168

Link:
Largest Study Finds Greater Reduction in Risk of CVD and Death From Bedtime Rather Than Morning Medication - Cath Lab Digest

BioMakerspace to open this coming IAP in Building 26 – The Tech

By Edwin SongOct. 31, 2019

A new biology makerspace, called the BioMakerspace, is scheduled to open this coming IAP in the basement of Building 26. The space, which is currently under construction, will be open to the entirety of the MIT community to be used for whatever the student users really want to use it for, said Justin Buck PhD 12 in an interview with The Tech. Buck is the manager of the BioMakerspace and is currently overseeing its construction.

Buck said the lab will have Biosafety Level 2 capabilities and contain all the basic equipment, including a tissue culture room, incubators, centrifuges, microscopes, pipettes, thermal cyclers, a refrigerator, a PCR, and common reagents.

Construction of the space is in the final stages and equipment is in the process of being obtained. We're really hoping to have a very large and active launch over IAP, said Buck. We plan to have workshops for folks to come and participate in if they don't have exposure to biology or would like to see and understand what its like to work with different projects.

MIT students looking to work in the lab must submit a project application and undergo lab training. Steve Wasserman, one of the biological engineering instructors who has helped run the biology makerspace program since its early stages, told The Tech in an interview that the lab has a stipulation that allows students to maintain intellectual property of the work they do in the lab and use it to launch their own companies.

A lounge next to the lab will provide a place to work and congregate. The idea that we're pursuing is that this facility will serve as the nucleus for a community that is interested in life science, Wasserman explained.

Construction began April 2019 after several years of what Buck described as a very successful pilot phase, which operated out of the bioengineering department teaching laboratories.

Wasserman said the idea for a biology makerspace program arose several years ago out of student demand. Students get all kinds of crazy ideas and they want to do them, and a lot of times there are barriers to doing them in various research labs around campus, Wasserman said, citing the lack of spaces with appropriate equipment, intellectual property rights, and supervision.

Past projects through the program range from therapeutic drug delivery to kombucha, mostly independent projects thought up by the students, Buck said. Thats what I think makes the space most unique and what it is. Perhaps its greatest value as an asset to the community is that it is open to any ideas.

Associate Provost Krystyn Van Vliet PhD 02 told The Tech in an interview that having an independent lab for the biology makerspace has several benefits over continued use of the bioengineering teaching labs, such as not having to risk disrupting classes being taught in the teaching labs and flexibility in regards to research groups and topics.

Teaching spaces have to have things set up just so, and they're not places where we tend to do projects that would mix different research groups, Van Vliet said. Creating a mechanism where students, postdocs, other kinds of research staff, and faculty can work on things together that might not be within the research interests and domain of the existing faculty is how new ideas get started.

Both Buck and Van Vliet mentioned the establishment of the biology makerspace as part of a campus-wide trend towards makerspaces. For example, Van Vliet pointed to the planned Project Manus community-wide makerspace that will be on the first floor of the Metropolitan Warehouse.

Buck said the BioMakerspace is the first space that is really enabled and focused on working with biology as a medium.

Construction of the BioMakerspace is conducted by Greene Construction and sponsored by the biological engineering and chemical engineering departments, along with a donor whose identity Buck declined to disclose.

Van Vliet said additional funds were provided by the MIT Committee for Renovation and Space Planning (CRSP), which she co-chairs. According to Van Vliet, CRSP was responsible for much of the behind-the-scenes work in arranging for the bio makerspace to be designed and built.

Along with Buck and Wasserman, several other biological and chemical engineering faculty and instructors, including the department heads, are closely involved in the project. Additionally, a BioMakers student groupis currently helping with planning and launching the itinerary of activities for IAP, Buck said.

Wasserman described student feedback as instrumental in the design of the layout and contents of the lab and lounge. In the more public areas, the windows are bigger. The windows get smaller and smaller as you go to more private places, Wasserman said. We asked in one of our surveys how open they wanted to space to be, ... and the students said that they didnt want to be in a fishbowl.

Students interested in the BioMakerspace are encouraged to contact Justin Buck at jbuck@mit.edu.

Here is the original post:
BioMakerspace to open this coming IAP in Building 26 - The Tech

Phlebotomy: Serena innovating on Dental Bioengineering to keep … – PRUnderground (press release)

At Serena Family & Cosmetic Dentistry in Clairemont, San Diego, we take pride in always being up to date on the latest technology and most innovative techniques in dentistry to benefit our patients and give them the quality service they deserve. Thats why we want to announce that Dr. Serena Kurt is now certified as a Phlebotomy Specialist. What is this and how does it benefit your Dental treatment? Let us explain.

Phlebotomy is the practice of drawing blood from patients and taking the blood specimens to the laboratory to prepare for testing. At first glance, this would seem unrelated to Dental Treatment or Dental Implants, but its not, it will benefit the patient in many ways that allow implants to settle much better once theyre installed, especially in drastic cases where the jawbone has deteriorated. However, this will allow you to heal faster and look as natural as ever.

Special state certification in the United States is required in California. To qualify to sit for an examination, candidates must complete a full phlebotomy course and provide documentation of clinical or laboratory experience. Dr. Kurt has now completed full certification to bring you all the commodities of this advanced treatment at an affordable price. Phlebotomy is used for Platelet Rich Plasma (PRP) procedure. PRP accelerates healing and enhances bone growth, which in turn stimulates osseointegration of dental implants. This means that if youre getting work done in our clinic, the procedure will allow the Doctor to add tissue to make regeneration and healing process much faster.

During the PRP procedure, a small amount of blood is drawn in preparation for dental implant treatment. PRP is a by-product of blood that is rich in platelets. Platelets are irregularly-shaped, colorless bodies that are present in the blood. Their sticky surface lets them, along with other substances, form clots to stop bleeding. Platelets contain growth factors (GFs), which serve as effective inducers of normal tissue repair. It also helps that this process is completely painless and will allow you to continue your daily activities. As we mentioned before, this process makes your teeth much more aesthetic, as it accelerates the natural process of rehabilitation, making it seem like you never had any work at all.

Due to the Platelets allowing your body to create new tissue by stimulating mesenchymal stem cells (MSCs). An article in The International Journal of Periodontics and Restorative Dentistry detailed a study regarding the use of Growth Factors in molar sites with bone defects. The authors of the article advocated the use of Growth Factors in immediate placement of implants at the time of tooth removal. They elaborate on how using this process practically guarantees the treatment will be successful, you will be able to preserve the bone, and soft tissue in the area wherein the implant is done, and superior esthetic results, helping you get back your beautiful smile in no time.

Like we stated before, few dental clinics in San Diego, especially in Clairemont, offer this treatment at the moment, but we keep innovating to meet the highest quality standards that you deserve, allowing us to compete with not only the top ranked Dental Clinics in the US, but the world. This is because not only can you get the highest quality materials and attention while getting, lets say, your crowns with us; but you can get them done with the most advanced German engineered machinery in as little as five minutes. Combined with this new technique, you wont have to worry about getting the quality treatment you need. Serena San Diego Dentist is the best option today for all the dental needs of you and your family.

With more than 20 years of expertise in the business, Dr. Serena Kurt and her San Diego dental office is your best option for the highest quality and personalized service you deserve.

About Serena San Diego Dentist

Serena Family & Cosmetic Dentistry offers top quality of dentistry in Clairemont, San Diego at affordable pricing! Dr. Serena Kurt has created more than 20,000 crowns and veneers during her 20 years of professional experience. As your official Clairemont, San Diego dentist and dental implant provider, Dr. Serena Kurt will ensure that you get only the finest and most suitable dental care that you cannot simply find anywhere else!

See the rest here:
Phlebotomy: Serena innovating on Dental Bioengineering to keep ... - PRUnderground (press release)

Fluence Bioengineering Improves Year-Round Quality and Consistency of Crop Production at Hllns Handelstrdgrd – Benzinga

Swedish producer of leafy greens, herbs, and ornamental flowers grows faster and better during winter than summer since switching from HPS to Fluence VYPRx PLUS LED solutions

Austin, TX (PRWEB) June 08, 2017

Fluence Bioengineering today announced Hllns Handelstrdgrd, one of Sweden's largest producers of organic leafy greens, herbs, and ornamental flowers, has seen a dramatic improvement in crop production since upgrading its supplemental greenhouse lighting from high pressure sodium (HPS) to Fluence LED-based solutions. The upgrade to Fluence LED solutions has increased bench turns, crop yield and quality, and energy efficiency coupled with a decrease in lead time and shrink.

To help Hllns Handelstrdgrd achieve their goals of increasing year-round, consistent crop production, Fluence developed lighting solutions specific to their unique growing conditions just south of the Arctic Circle in Northern Sweden. To learn more, and to get a behind-the-scenes look into Hllns Handelstrdgrd's operation, visit http://fluence.science/hallnas

"We are seeing reduced lead times and higher yields under the Fluence LED systems, with finished product quality that exceeds everything we have seen before," said Bjrn Isacsson, owner at Hllns Handelstrdgrd. "Not only have the products from Fluence surpassed our expectations, but the team has proven invaluable with support and services to help our business grow."

"All we can see are these great results: better quality and more compact plants," said Philip Stawarz, Head Grower at Hllns Handelstrdgrd. "Growing with HPS was like it was, lamps on or off. Now with Fluence, life is much more interesting as I can manipulate plants how I want."

With the addition of VYPRx PLUS lighting solutions, Hllns is now able to grow higher quality plants faster during winter (when there is little sunlight), than during the summer due to the improved light intensity and spectrum, and ideal growing environment Fluence lighting solutions create. The company has deployed VYPRx PLUS with PhysioSpec Greenhouse, a broad spectrum for full-cycle plant growth and development, along with VYPRx PLUS with AnthoSpec, a custom narrow-band spectrum which increases anthocyanin accumulation in lettuce. The deployment of AnthoSpec resulted in a deep red color and higher antioxidant properties which were previously unattainable under HPS or sunlight.

"It is a pleasure working with the team at Hllns Handelstrdgrd as we collaborate to develop solutions which have proven to successfully help them achieve their cultivation and financial goals," said Nick Klase, Co-Founder and CEO at Fluence Bioengineering. "Every environment and every customer's needs are uniquethat's why we focus on building deep relationships with our customers to achieve results which are unattainable by any other means."

In addition to Hllns Handelstrdgrd, VYPRx PLUS LED systems have been deployed at hundreds of commercial crop production facilities and research institutions worldwide. Fluence lighting solutions have been independently verified to be the most energy efficient, powerful and efficacious, resulting in high-quality, high-yield crop production facilities. Learn more at https://fluence.science/vypr

About Fluence Bioengineering Fluence Bioengineering is a photobiology design company exploring physiological plant development under various levels of photosynthetically active radiation and custom spectra. The company partners with leading research institutions to engineer the most powerful and efficient horticulture lighting solutions for both science and commercial applications. All Fluence systems are designed and built in Austin, TX, USA. https://fluence.science

###

For the original version on PRWeb visit: http://www.prweb.com/releases/2017/06/prweb14401620.htm

Continued here:
Fluence Bioengineering Improves Year-Round Quality and Consistency of Crop Production at Hllns Handelstrdgrd - Benzinga

Around the Pier: The Bioengineering Behind the Beauty – Scripps Oceanography News

Marine phytoplankton are famously photogenic.

Take, for instance, diatoms. They are among the most common type of phytoplankton and are especially breathtaking: their cell walls are made of silica, a glass-like compound, and take a variety of forms including discs, tubes, and star-like structures.

Scientists have long sought to understand the factors that contribute to the diversity of phytoplankton.

Presumably all these different shapes have some ecological meaning, said Andrew Barton, an assistant professor at Scripps Institution of Oceanography and the Biological Sciences Division at the University of California San Diego. Some shapes might be hard to eat, or maybe are advantageous for acquiring scarce resources.

Barton has just received the Simons Foundation Early Career Investigation in Marine Microbial Ecology and Evolution Award, which will support an interdisciplinary research project to attempt to answer this question.

The project will use a combination of underwater microscope data from the Scripps Pier Plankton Camera operated by the Jaffe Laboratory for Underwater Imaging, environmental data from the Southern California Coastal Ocean Observing System (SCCOOS), and numerical models that simulate plankton communities to understand the ecological reasons for the poorly understood diversity in phytoplankton shapes and sizes.

The Scripps Plankton Camera is an underwater microscope deployed at the Scripps Pier that uses real-time image processing and object detection to monitor plankton species and abundance. Barton and his team will combine data collected by the microscope and the SCCOOS environmental data to look for correlations between environmental conditions and abundance of different kinds of plankton over time. The information they gather will help researchers understand the local environment better. Barton and his team will also create numerical models to extrapolate the trends they see to the rest of the ocean.

We can take what we learn from the data at Scripps Pier and try to extrapolate that to a larger-scale perspective, Barton said. For example, where in the global ocean is it advantageous to be a spherical cell? Where it is advantageous to form large colonies of cells? We can try to make some estimates of how cell and colony morphology vary across the planet.

The outcomes of the project could also help answer oceanographic questions beyond phytoplankton ecology. Phytoplankton are an important part of the carbon cycle and their contributions to carbon dioxide uptake from the atmosphere and oxygen creation is a significant factor in most oceanographic and climate models.

Most models and theories about how phytoplankton do what they do are predicated on them being spheres, which is obviously untrue, Barton said.

The size and shape of organisms in the ocean is important in determining where carbon and energy go in the food web, and whether the carbon absorbed will be exported from the ocean's surface to the deep sea or sediments. Providing updated information on phytoplankton morphology and how it varies throughout the worlds oceans could improve sciences understanding of the carbon cycle.

For example, if you have a really dense large cell like a diatom, it will sink from the ocean's surface, resulting in a loss of organic matter, Barton said, whereas if you have a small cell, it may just stay near the surface and be recycled locally.

The interdisciplinary research will involve Jules Jaffe, a research oceanographer in the Marine Physical Laboratory at Scripps, Paul Roberts, an engineer in Jaffes lab, and Peter Franks, a professor of biological oceanography who will help the team estimate water column turbulence and understand how turbulence in the ocean shapes cell and colony morphology.

I'm really grateful for the Simons Foundation support and happy that we now have the team and the tools to do some compelling and important science, Barton said.

And as Barton is a relatively new faculty member, this big project will be an excellent opportunity for him to collaborate with other researchers at Scripps.

This is kind of a kick-off in terms of collaborating with a Scripps team and using data collected here at the institution, he said. Im very excited.

Mallory Pickett

The rest is here:
Around the Pier: The Bioengineering Behind the Beauty - Scripps Oceanography News

Research | UW Bioengineering

Research Laura Elizabeth Wright 2017-02-28T13:38:36+00:00

With a strong base of external funding, UW Bioengineering faculty and students conduct a mix of basic and applied research and engage in interdisciplinary collaborations that bridge traditional boundaries between engineering, physical sciences and medicine.

Developing new engineering approaches for the repair and replacement of human tissues damaged by injury, illness and aging.

Exploring how molecular-level interactions drive cellular behavior, and designing new molecular systems for medical applications.

Creating cost-effective medical technologies for use in developed and developing countries.

Developing tools for basic science and medicine, mainly in areas of medical imaging.

Analyzing the interacting networks that give rise to an organisms function, and using that knowledge to create new organisms to treat disease.

UW Bioengineerings interdisciplinary research centers create unique communities for exploring a range of research frontiers.

Learn more about UW Bioengineerings research centers.

We are proud of all our faculty, staff and students, and the many awards they earn for their work in teaching, mentoring and improving lives through bioengineering research and innovation.

Learn more about UW Bioengineerings awards and recognition.

Read more:
Research | UW Bioengineering

Clemson’s 15 patents in 2016 span bioengineering, advanced materials – Clemson Newsstand

CLEMSON, South Carolina Rapid diagnostic tests for point-of-care diagnostics, diabetic-resistant coatings, HIV inhibitors and an impact-resistant, corrosion-prohibiting coating were among the 15 innovations for which Clemson University researchers received patents in 2016.

Tanju Karanfil, vice president for research at Clemson University, says the patent awards are one example of the impact Clemson makes on the region. Image Credit: Craig Mahaffey / Clemson University

The Clemson University Research Foundation(CURF) facilitates and manages technology transfer for Clemson faculty. Collaboration between researchers and CURF has produced more than 150 patents that are nowavailable to the private sector for licensing.

The patent recipients received special recognition recently at an annual award event sponsored by theClemson Inventors Club, a select group of faculty chosen for their high level of research activity, which often produces inventions.

Invention and innovation in research are just a few ways Clemson impacts the world, said Tanju Karanfil, vice president for research at Clemson. Congratulations to all the inventors for their hard work and dedication to academic research.

Bob Quinn, executive director of theSouth Carolina Research Authority (SCRA) outlined the new vision for the organization.

The patent awards are a great representation of the innovation happening at Clemson, Quinn said. We were honored to be able to share how SCRA works with innovators to commercialize their technologies.

Our annual patent awards recognize the quality of the research being done at Clemson, said Casey Porto, executive director of the foundation. Its a privilege to honor these researchers and celebrate their contributions to innovation that starts at Clemson and moves into the marketplace.

For a complete list of 2016 Clemson patents and recipients,click here.

For a complete list of all patents awarded to Clemson faculty, click here.

END

Read this article:
Clemson's 15 patents in 2016 span bioengineering, advanced materials - Clemson Newsstand

UH students turn alcohol project into hand sanitizer – UH System Current News

CTAHR students distilling alcohol into hand sanitizer.

Desperate times call for imaginative measures. Instead of making rum and ginger beer, students in the University of Hawaii at Mnoas College of Tropical Agriculture and Human Resources (CTAHR) Department of Molecular Biosciences and Bioengineering (MBBE) are using the knowledge they gained to distill hand sanitizer to help combat COVID-19.

The project began in early March, when classmates in fermentation biochemistry were originally planning to make rum for the annual CTAHR Awards Banquet by fermenting sugar and water to be distilled into alcohol. However, public shortages of hand sanitizer caused by COVID-19 led them to change direction and turn the product into hand sanitizer.

The class only had to alter a few steps in the process, including distilling the spirit to a greater percentage of ethanol. The Centers for Disease Control and Prevention guidelines call for hand sanitizers to be at least 60 percent alcohol to kill the coronavirus, and the students product will meet that mark.

Fermentation biochemistry course consultant and MBBE PhD candidate Nick Sinclair is excited about the project. We are hoping that all of Hawaii will be able to benefit from us alleviating at least our section of the populace from having to buy hand sanitizer, he said. This is also a learning experience for everyone involved, so this experience enriches our education as well.

After distillation, the pulp of fresh, locally grown aloe provided by specialist Ken Leonhardt from the Department of Tropical Plant and Soil Sciences was extracted and blended smooth. This creates a gel-like consistency and keeps the spirit from drying out hands excessively. Next, it will be mixed with the distilled alcohol and the product will be tested.

Eventually, we hope to be able to distribute it at the very least to people around us, but the class is also working on other channels of distribution, said Sinclair.

Go here to read the rest:
UH students turn alcohol project into hand sanitizer - UH System Current News

Nasal gel to prevent COVID-19 to be made in IIT Bombay – Deccan Herald

As part of a multi-pronged strategy to combat COVID-19, a nasal gel is being made.

The Indian Institute of Technology-Bombay is playing a lead role in the project initiated by the Department of Science and Technology (DST).

"The nasal gel, being developed in conjunction with other protective measures, will provide a strong extra layer of defense," according to Prof Ashutosh Sharma, Secretary, DST.The Science and Engineering Research Board (SERB), a statutory body of the DST, is supporting a technology by the Department of Biosciences and Bioengineering (DBB), IIT Bombay for capturing and the inactivation of novel coronavirus, the causative agent of COVID-19.

For latest updates and live news on coronavirus, click here

The funding will help the team from the Department of Biosciences and Bioengineering, IIT Bombay develop a gel that can be applied to nasal passage, which is a major entry point of the coronavirus, according to a press statement.

This solution is not only expected to protect the safety of health workers, but can also lead to reduction in community transmission of COVID-19, thereby helping disease management.Given the contagious nature of COVID-19, health providers, including doctors and nurses, are at maximum risk while taking care of COVID-19 patients, particularly asymptomatic ones who cannot be detected and pose a greater risk in spreading the disease.

The team is planning a two-pronged approach to limit transmission of the SARS-CoV-2 virus, the causative agent of COVID-19.

Track state-wise confirmed coronavirus cases here

Primarily, since viruses replicate within host cells of the lungs, the first component of the strategy will be to inhibit the binding of viruses to host cells. While this is expected to reduce host cell infection, viruses will still remain active, therefore raising the need to inactivate them.

Secondly, biological molecules would be incorporated, which would inactivate the trapped viruses in a manner similar to that of detergents. Upon completion, this approach will lead to development of gels that can be locally applied in the nasal cavity.

"Our healthcare workers and others working in the front-line of the fight against the virus deserve a fool-proof, 200% protection. The nasal gel, being developed in conjunction with other protective measures, will provide a strong extra layer of defence," said Prof Sharma.

Prof Kiran Kondabagil, Prof Rinti Banerjee, Prof Ashutosh Kumar and Prof Shamik Sen from the IIT Bombay will be part of this project. The team has expertise in the areas encompassing virology, structural biology, biophysics, biomaterials, and drug delivery and it is expected that the technology would be ready in about nine months.

Visit link:
Nasal gel to prevent COVID-19 to be made in IIT Bombay - Deccan Herald